These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30701022)

  • 21. RET fusion as a novel driver of medullary thyroid carcinoma.
    Grubbs EG; Ng PK; Bui J; Busaidy NL; Chen K; Lee JE; Lu X; Lu H; Meric-Bernstam F; Mills GB; Palmer G; Perrier ND; Scott KL; Shaw KR; Waguespack SG; Williams MD; Yelensky R; Cote GJ
    J Clin Endocrinol Metab; 2015 Mar; 100(3):788-93. PubMed ID: 25546157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multikinase Inhibitors for the Treatment of Progressive, Metastatic Medullary Thyroid Cancer - An Evolving Paradigm.
    Jarzab B; Krajewska J
    Eur Endocrinol; 2014 Aug; 10(2):145-150. PubMed ID: 29872479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis.
    Trimboli P; Castellana M; Virili C; Giorgino F; Giovanella L
    Front Endocrinol (Lausanne); 2018; 9():224. PubMed ID: 29774010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone Deacetylase Inhibitors: A Novel Therapeutic Weapon Against Medullary Thyroid Cancer?
    Damaskos C; Garmpis N; Valsami S; Spartalis E; Antoniou EA; Tomos P; Karamaroudis S; Zoumpou T; Pergialiotis V; Stergios K; Michaelides C; Kontzoglou K; Perrea D; Nikiteas N; Dimitroulis D
    Anticancer Res; 2016 Oct; 36(10):5019-5024. PubMed ID: 27798860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells.
    Bertazza L; Barollo S; Radu CM; Cavedon E; Simioni P; Faggian D; Plebani M; Pelizzo MR; Rubin B; Boscaro M; Pezzani R; Mian C
    J Cell Mol Med; 2015 Sep; 19(9):2244-52. PubMed ID: 26081844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer.
    Saronni D; Gaudenzi G; Dicitore A; Carra S; Cantone MC; Borghi MO; Barbieri A; Mignani L; Hofland LJ; Persani L; Vitale G
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of hereditary medullary thyroid carcinoma.
    Pappa T; Alevizaki M
    Endocrine; 2016 Jul; 53(1):7-17. PubMed ID: 26839093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
    Ito Y; Onoda N; Ito KI; Sugitani I; Takahashi S; Yamaguchi I; Kabu K; Tsukada K
    Thyroid; 2017 Sep; 27(9):1142-1148. PubMed ID: 28635560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on the cytologic and molecular features of medullary thyroid carcinoma.
    Pusztaszeri MP; Bongiovanni M; Faquin WC
    Adv Anat Pathol; 2014 Jan; 21(1):26-35. PubMed ID: 24316908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cabozantinib for the treatment of advanced medullary thyroid cancer.
    Nagilla M; Brown RL; Cohen EE
    Adv Ther; 2012 Nov; 29(11):925-34. PubMed ID: 23104465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma.
    Dadu R; Hu MN; Grubbs EG; Gagel RF
    Recent Results Cancer Res; 2015; 204():227-49. PubMed ID: 26494392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.
    Hedayati M; Zarif Yeganeh M; Sheikholeslami S; Afsari F
    Crit Rev Clin Lab Sci; 2016 Aug; 53(4):217-27. PubMed ID: 26678667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro.
    Ferrari SM; Fallahi P; La Motta C; Bocci G; Corrado A; Materazzi G; Galleri D; Piaggi S; Danesi R; Da Settimo F; Miccoli P; Antonelli A
    Surgery; 2014 Nov; 156(5):1167-76. PubMed ID: 25151558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New drugs for medullary thyroid cancer: new promises?
    Spitzweg C; Morris JC; Bible KC
    Endocr Relat Cancer; 2016 Jun; 23(6):R287-97. PubMed ID: 27185870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing tyrosine kinase inhibitors side effects in thyroid cancer.
    Krajewska J; Paliczka-Cieslik E; Jarzab B
    Expert Rev Endocrinol Metab; 2017 Mar; 12(2):117-127. PubMed ID: 30063430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma.
    Santarpia L; Ye L; Gagel RF
    J Intern Med; 2009 Jul; 266(1):99-113. PubMed ID: 19522829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.
    Chu YH; Lloyd RV
    Endocr Pathol; 2016 Dec; 27(4):312-324. PubMed ID: 27539727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting RET for thyroid cancer therapy.
    Lanzi C; Cassinelli G; Nicolini V; Zunino F
    Biochem Pharmacol; 2009 Feb; 77(3):297-309. PubMed ID: 19028457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells.
    Klubo-Gwiezdzinska J; Jensen K; Costello J; Patel A; Hoperia V; Bauer A; Burman KD; Wartofsky L; Vasko V
    Endocr Relat Cancer; 2012 Jun; 19(3):447-56. PubMed ID: 22389381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cells.
    Kushchayeva Y; Jensen K; Recupero A; Costello J; Patel A; Klubo-Gwiezdzinska J; Boyle L; Burman K; Vasko V
    J Clin Endocrinol Metab; 2014 May; 99(5):E734-45. PubMed ID: 24483157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.